|
08-6110-4
|
6505-01-334-9318
|
Usp Sodium Bicarbonate |
National Medical Care
|
|
Quote
|
|
NATURALYTE
|
6505-01-334-9318
|
Usp Sodium Bicarbonate |
National Medical Care
|
|
Quote
|
|
NATURALYTE 6000 RX-10
|
6505-01-334-9318
|
Usp Sodium Bicarbonate |
National Medical Care
|
|
Quote
|
|
RIOPAN
|
6505-01-334-9321
|
Usp Magaldrate Tablets |
Wyeth Consumer Healthcare
|
|
Quote
|
|
NDC00046-3194-30
|
6505-01-334-9321
|
Usp Magaldrate Tablets |
Wyeth Consumer Healthcare
|
|
Quote
|
|
NDC00573-3194-30
|
6505-01-334-9321
|
Usp Magaldrate Tablets |
Wyeth Consumer Healthcare
|
|
Quote
|
|
A93G044
|
6505-01-334-9322
|
Concentrat Hemodialysis Solution |
Department of the Army
|
|
Quote
|
|
RENASOL
|
6505-01-334-9322
|
Concentrat Hemodialysis Solution |
Minntech Corp
|
|
Quote
|
|
SB-1020
|
6505-01-334-9322
|
Concentrat Hemodialysis Solution |
Minntech Corp
|
|
Quote
|
|
A90L124
|
6505-01-334-9468
|
Nitroglycerin In Dextrose Inject |
Department of the Army
|
|
Quote
|
|
1A0696
|
6505-01-334-9468
|
Nitroglycerin In Dextrose Inject |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00338-1051-02
|
6505-01-334-9468
|
Nitroglycerin In Dextrose Inject |
Baxter Healthcare Corp
|
|
Quote
|
|
F90L136
|
6505-01-335-2642
|
Niacin Extended-release Capsules |
Air Force Medical Logistics Office
|
|
Quote
|
|
NDC10135-0187-10
|
6505-01-335-2642
|
Niacin Extended-release Capsules |
Marlex Pharmaceutical
|
|
Quote
|
|
NDC00536-5225-98
|
6505-01-335-3513
|
Us Triamcinolone Acetonide Cream |
Rugby Group Inc
|
|
Quote
|
|
MAOX
|
6505-01-335-7401
|
Usp Magnesium Oxide Tablets |
Manne Kenneth a Co
|
|
Quote
|
|
NDC10706-0837-01
|
6505-01-335-7401
|
Usp Magnesium Oxide Tablets |
Manne Kenneth a Co
|
|
Quote
|
|
RENASOL
|
6505-01-335-7402
|
Concentrat Hemodialysis Solution |
Medivators Inc.
|
|
Quote
|
|
SB-1003
|
6505-01-335-7402
|
Concentrat Hemodialysis Solution |
Medivators Inc.
|
|
Quote
|
|
NDC00781-1883-10
|
6505-01-335-9163
|
Usp Ranitidine Tablets |
Sandoz Inc.
|
|
Quote
|
|
NDC49884-0544-10
|
6505-01-335-9163
|
Usp Ranitidine Tablets |
Par Pharmaceutical, Inc.
|
|
Quote
|
|
RANITADINE
|
6505-01-335-9163
|
Usp Ranitidine Tablets |
Par Pharmaceutical, Inc.
|
|
Quote
|
|
NDC50458-0094-05
|
6505-01-335-9388
|
Fentanyl Transdermal System |
Janssen Pharmaceutica Inc
|
|
Quote
|
|
NDC00378-9123-98
|
6505-01-335-9389
|
Fentanyl Transdermal System |
Mylan Pharmaceuticals Inc
|
|
Quote
|
|
DURAGESIC
|
6505-01-335-9389
|
Fentanyl Transdermal System |
Janssen Pharmaceutica Inc
|
|
Quote
|
|
NDC50458-0093-05
|
6505-01-335-9389
|
Fentanyl Transdermal System |
Janssen Pharmaceutica Inc
|
|
Quote
|
|
NDC50458-0092-05
|
6505-01-335-9390
|
Fentanyl Transdermal System |
Janssen Pharmaceutica Inc
|
|
Quote
|
|
NDC00378-9121-98
|
6505-01-335-9391
|
Fentanyl Transdermal System |
Mylan Pharmaceuticals Inc
|
|
Quote
|
|
DURAGESIC
|
6505-01-335-9391
|
Fentanyl Transdermal System |
Janssen Pharmaceutica Inc
|
|
Quote
|
|
NDC50458-0091-05
|
6505-01-335-9391
|
Fentanyl Transdermal System |
Janssen Pharmaceutica Inc
|
|
Quote
|
|
A90G153
|
6505-01-335-9394
|
Erythromycin Delayed-release Cap |
Department of the Army
|
|
Quote
|
|
NDC00904-2465-60
|
6505-01-335-9394
|
Erythromycin Delayed-release Cap |
Major Pharmaceuticals Inc
|
|
Quote
|
|
NDC00074-6301-13
|
6505-01-335-9394
|
Erythromycin Delayed-release Cap |
Abbott Laboratories Inc
|
|
Quote
|
|
NDC00071-0696-24
|
6505-01-335-9394
|
Erythromycin Delayed-release Cap |
Parke-davis
|
|
Quote
|
|
A91E004
|
6505-01-335-9706
|
Betaxolol Hydrochloride Ophthalm |
Department of the Army
|
|
Quote
|
|
BETOPTIC S DROP-TAINER
|
6505-01-335-9706
|
Betaxolol Hydrochloride Ophthalm |
Alcon Laboratories, Inc.
|
|
Quote
|
|
BETOPTIC S
|
6505-01-335-9706
|
Betaxolol Hydrochloride Ophthalm |
Alcon Laboratories, Inc.
|
|
Quote
|
|
NDC00065-0246-05
|
6505-01-335-9706
|
Betaxolol Hydrochloride Ophthalm |
Alcon Laboratories, Inc.
|
|
Quote
|
|
A90G156
|
6505-01-335-9919
|
Sodium Sulfacetamide And Sulfur |
Department of the Army
|
|
Quote
|
|
NDC00065-0028-25
|
6505-01-335-9919
|
Sodium Sulfacetamide And Sulfur |
Sanofi-aventis U.s. Inc
|
|
Quote
|
|
NDC00066-0028-25
|
6505-01-335-9919
|
Sodium Sulfacetamide And Sulfur |
Dermik Laboratories Inc
|
|
Quote
|
|
SULFACET-R
|
6505-01-335-9919
|
Sodium Sulfacetamide And Sulfur |
Dermik Laboratories Inc
|
|
Quote
|
|
SULFACET-R LOTION
|
6505-01-335-9919
|
Sodium Sulfacetamide And Sulfur |
Dermik Laboratories Inc
|
|
Quote
|
|
NDC00066-0028-25
|
6505-01-335-9919
|
Sodium Sulfacetamide And Sulfur |
Dermik Laboratories Inc
|
|
Quote
|
|
SULFOXYL
|
6505-01-336-0560
|
Benzoyl Peroxide And Sulfur Loti |
Stiefel Laboratories Inc
|
|
Quote
|
|
SULFOXYL LOTION
|
6505-01-336-0560
|
Benzoyl Peroxide And Sulfur Loti |
Stiefel Laboratories Inc
|
|
Quote
|
|
A90G155
|
6505-01-336-0560
|
Benzoyl Peroxide And Sulfur Loti |
Department of the Army
|
|
Quote
|
|
NDC00145-3518-07
|
6505-01-336-0560
|
Benzoyl Peroxide And Sulfur Loti |
Stiefel Laboratories Inc
|
|
Quote
|
|
NDC00145-3518-07
|
6505-01-336-0560
|
Benzoyl Peroxide And Sulfur Loti |
Stiefel Laboratories Inc
|
|
Quote
|
|
NDC00074-6214-53
|
6505-01-336-3618
|
Divalproex Sodium Delayed-releas |
Abbott Laboratories
|
|
Quote
|
|
DEPAKOTE
|
6505-01-336-3618
|
Divalproex Sodium Delayed-releas |
Abbott Laboratories
|
|
Quote
|
|
CIPRO
|
6505-01-336-6178
|
Ciprofloxacin Hydrochloride In D |
Bayer Pharmaceuticals Corporation
|
|
Quote
|
|
CIPRO INJECTION
|
6505-01-336-6178
|
Ciprofloxacin Hydrochloride In D |
Bayer Pharmaceuticals Corporation
|
|
Quote
|
|
NDC00026-8552-36
|
6505-01-336-6178
|
Ciprofloxacin Hydrochloride In D |
Bayer Corporation
|
|
Quote
|
|
NDC00026-8552-36
|
6505-01-336-6178
|
Ciprofloxacin Hydrochloride In D |
Bayer Pharmaceuticals Corporation
|
|
Quote
|
|
NDC00409-4777-23
|
6505-01-336-6178
|
Ciprofloxacin Hydrochloride In D |
Hospira, Inc.
|
|
Quote
|
|
NDC00781-3239-09
|
6505-01-336-6178
|
Ciprofloxacin Hydrochloride In D |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
|
NDC00409-4777-02
|
6505-01-336-6179
|
Ciprofloxacin Hydrochloride In D |
Hospira, Inc.
|
|
Quote
|
|
CEPTAZ
|
6505-01-336-6182
|
Usp Ceftazidime For Injection |
Glaxo Wellcome Inc
|
|
Quote
|
|
NDC00173-0416-00
|
6505-01-336-6182
|
Usp Ceftazidime For Injection |
Glaxo Wellcome Inc
|
|
Quote
|
|
NDC00173-0442-00
|
6505-01-336-6184
|
Ondansetron Hydrochloride Inject |
Veterans Health
|
|
Quote
|
|
ZOFRAN INJECTION
|
6505-01-336-6184
|
Ondansetron Hydrochloride Inject |
Glaxo Wellcome Inc
|
|
Quote
|
|
ZOFRAN
|
6505-01-336-6184
|
Ondansetron Hydrochloride Inject |
Glaxo Wellcome Inc
|
|
Quote
|
|
NDC00173-0442-00
|
6505-01-336-6184
|
Ondansetron Hydrochloride Inject |
Glaxo Wellcome Inc
|
|
Quote
|
|
NDC63323-0374-20
|
6505-01-336-6184
|
Ondansetron Hydrochloride Inject |
Fresenius Kabi Usa Llc
|
|
Quote
|
|
DYNACIRC
|
6505-01-336-6188
|
Isradipine Capsules |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
|
NDC00078-0227-05
|
6505-01-336-6188
|
Isradipine Capsules |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
|
DYNACIRC
|
6505-01-336-6190
|
Isradipine Capsules |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
|
NDC00078-0226-44
|
6505-01-336-6190
|
Isradipine Capsules |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
|
COLESTID
|
6505-01-336-6194
|
Colestipol Hydrochloride For Ora |
Pharmacia & Upjohn Company
|
|
Quote
|
|
NDC00009-0260-17
|
6505-01-336-6194
|
Colestipol Hydrochloride For Ora |
Pharmacia & Upjohn Company
|
|
Quote
|
